Neogen (NEOG) EPS (Diluted) Growth (3y) (2013 - 2026)
Neogen (NEOG) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 63.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 30.57% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 29.56% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | -59.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -59.57% |
| Nov 30, 2025 | 27.67% |
| Aug 31, 2025 | 51.28% |
| May 31, 2025 | -191.71% |
| Feb 28, 2025 | -44.19% |
| Nov 30, 2024 | -184.45% |
| Aug 31, 2024 | -33.30% |
| May 31, 2024 | -29.80% |
| Feb 29, 2024 | -27.55% |
| Nov 30, 2023 | -28.23% |
| Aug 31, 2023 | -64.02% |
| May 31, 2023 | -39.77% |
| Feb 28, 2023 | -30.96% |
| Nov 30, 2022 | -48.24% |
| Aug 31, 2022 | -29.71% |
| May 31, 2022 | -4.44% |
| Feb 28, 2022 | -26.07% |
| Nov 30, 2021 | -13.10% |
| Aug 31, 2021 | 3.05% |
| May 31, 2021 | -7.33% |